Proteomic study of peptide deformylase inhibition in Streptococcus pneumoniae and Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1656-1663

  Wang, Wen ^a   White, Richard ^a   Yuan, Zhengyu ^a,b  

^a Vicuron Pharmaceuticals   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; N (5 FLUORO 1 OXIDO 2 PYRIDINYL) 1 [2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANOYL]PROLINAMIDE; PEPTIDE; PEPTIDE DEFORMYLASE; PEPTIDE DEFORMYLASE INHIBITOR; PROTEOME;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DEFORMYLATION; DRUG CLASSIFICATION; ENZYME INHIBITION; FORMYLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMIDOHYDROLASES; BACTERIAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; HYDROGEN-ION CONCENTRATION; KINETICS; MICROBIAL SENSITIVITY TESTS; PEPTIDE MAPPING; PEPTIDES; PROTEOME; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33646438509     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1656-1663.2006     Document Type: Article

References (22)

1. Apfel, C. M., H. Locher, S. Evers, B. Takács, C. Hubschwerlen, W. Pirson, M. G. P. Page, and W. Keck. 2001. Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob. Agents Chemother. 45:1058-1064.
2. Ball, L. A., and P. Kaesberg. 1973. Cleavage of the N-terminal formylmethionine residue from a bacteriophage coat protein in vitro. J. Mol. Biol. 79:531-537.
3. Bandow, J. E., D. Becher, K. Buttner, F. Hochgrafe, C. Freiberg, H. Brotz, and M. Hecker. 2003. The role of peptide deformylase in protein biosynthesis: a proteomic study. Proteomics 3:299-306.
4. Bandow, J. E., H. Brötz, L. I. O. Leichert, H. Labischinski, and M. Hecker. 2003. Proteomic approach to understanding antibiotic action. Antimicrob. Agents Chemother. 47:948-955.
5. Fritsche, T. R., H. S. Sader, R. Cleeland, and R. N. Jones. 2005. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance. Antimicrob. Agents Chemother. 49:1468-1476.
6. Fu, H., C. Dahlgren, and J. Bylund. 2003. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy. Antimicrob. Agents Chemother. 47:2545-2550.
7. Giglione, C., A. Serero, M. Pierre, B. Boisson, and T. Meinnel. 2000. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. 19:5916-5929.
8. Giglione, C., M. Pierre, and T. Meinnel. 2000. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents. Mol. Microbiol. 36:1197-1205.
9. Housman, D., D. Gillespie, and H. F. Lodish. 1972. Removal of formylmethionine residue from nascent bacteriophage f2 protein. J. Mol. Biol. 65:163-166.
10. Jain, R., D. Chen, R. J. White, D. V. Patel, and Z. Yuan. 2005. Bacterial peptide deformylase inhibitors: a new class of antibacterial agents. Curr. Med. Chem. 12:763-771.
11. Jones, R. N., G. J. Meet, H. S. Sader, and T. R. Pritsche. 2004. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J. Antimicrob. Chemother. 53:804-807.
12. Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709.
13. Lee, M. D., Y. She, M. J. Soskis, C. P. Borella, J. R. Gardner, P. A. Hayes, B. M. Dy, M. L. Heaney, M. R. Philips, W. G. Bornmann, F. M. Sirotnak, and D. A. Scheinberg. 2004. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-hased antibiotics. J. Clin. Investig. 114:1107-1116.
14. Margolis, P. S., C. J. Hackbarth, D. C. Young, W. Wang, D. Chen, Z. Yuan, R. White, and J. Trias. 2000. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. 44:1825-1831.
15. Margolis, P., C. Hackbarth, S. Lopez, M. Maniar, W. Wang, Z. Yuan, R. White, and J. Trias. 2001. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB. Antimicrob. Agents Chemother. 45:2432-2435.
16. Mazel, D., S. Pochet, and P. Marliere. 1994. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J. 13:914-923.
17. Met formyltransferase. J. Bacteriol. 176:7387-7390.
18. Meinnel, T., Y. Mechulam, and S. Blanquet. 1993. Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli. Biochimie 75:1061-1075.
19. Nguyen, K. T., X. Hu, C. Colton, R. Chakrabarti, M. X. Zhu, and D. Pei. 2003. Characterization of a human peptide deformylase: implications for antibacterial drug design. Biochemistry 42:9952-9958.
20. Shinabarger, D. L., K. R. Marotti, R. W. Murray, A. H. Lin, E. P. Melchior, S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Buysse. 1997. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41:2132-2136.
21. Specter, S., J. M. Flynn, B. Tidor, T. A. Baker, and R. T. Sauer. 2003. Expression of N-formylated proteins in Escherichia coli. Protein Expr. Purif. 32:317-322.
22. Yuan, Z., J. Trias, and R. J. White. 2001. Deformylase as a novel antibacterial target. Drug Discov. Today 6:954-961.